The Association of Health Insurance and Quality of Life in Type One Diabetics


  • Ally Wang Ellington High School
  • Mrs. McGinn Ellington High School



type 1 diabetes, health insurance, quality of life


The main purpose of this study was to investigate the correlation between health insurance and the quality of life of type 1 diabetic adults in Connecticut. Type 1 diabetics over the age of 26 living in Connecticut were invited to participate in a mixed methods case study.  Quality of life data was collected from a questionnaire with questions drawn from the 12-Item Short Form Health Survey and the Appraisal of Diabetes Scale. Each participant was assigned a quality of life score after taking the questionnaire. After taking the survey, a semi-structured interview was conducted with each participant with questions assessing their health insurance plan, access to care, and self-perception of quality of life. The quality of life scores from the survey were cross-referenced with how each participant responded in the interview, then analyzed The average quality of life score was 37, revealing a below average quality of life for type 1 diabetic adults in Connecticut. Patients reported in the interviews that health insurance helps maintain quality of life, but can restrict individuals from improving. The interviews also revealed higher levels of concern for the financial burden of diabetes and the effectiveness of insurance. The study concluded that type 1 diabetics face quality of life disparities. Health insurance effectively maintains a level of quality of life, but often restricts individuals from elevating themselves. 


Download data is not yet available.

Author Biography

Mrs. McGinn, Ellington High School


Department Head of the Social Studies department at Ellington High School,  Instructional Leader in the EHS building, AP CAPSTONE instructor for EHS. Teaches both AP Seminar & AP Research. Microeconomics Preceptor for the University of Connecticut's ECE Microeconomics class and an AP Microeconomics instructor. Also teaches AP Government & Politics. Has been teaching for 14 years in the high school, has been an AP instructor for 8 years and an ECE Preceptor for 6 years. 

I facilitated Ally's progress through her AP Research project, and evaluated and scored the Oral Presentation & Defense for her AP exam. 

References or Bibliography


Alvarado-Martel, D., Velasco, R., Sánchez-Hernández, R. M., Carrillo, A., Nóvoa, F. J., &

Wägner, A. M. (2015). Quality of life and type 1 diabetes: a study assessing patients' perceptions and self-management needs. Patient preference and adherence, 9, 1315–1323.

Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta,

GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2020.

Connecticut Department of Public Health. Connecticut Diabetes Statistics Report, 2016.

Hartford, CT: Connecticut Department of Public Health; 2016.

Diabetes—Symptoms and causes. (n.d.). Mayo Clinic. Retrieved April 12, 2021, from

Hayes, C. J., Bhandari, N. R., Kathe, N., & Payakachat, N. (2017). Reliability and validity of the

medical outcomes study short form-12 version 2 (SF-12v2) in adults with non-cancer pain. Healthcare, 5(2).

Insulin cost and pricing trends. (n.d.). AAF. Retrieved April 13, 2021, from

Jonathan R. Bouchard, M. S. (2018). Estimating the real-world cost of diabetes mellitus in the

united states during an 8-year period using 2 cost methodologies.

Laffel, L. M. B., Connell, A., Vangsness, L., Goebel-Fabbri, A., Mansfield, A., & Anderson, B.

J. (2003). General Quality of Life in Youth With Type 1 Diabetes: Relationship to patient management and diabetes-specific family conflict. Diabetes Care, 26(11), 3067–3073.

Lagasse, J. (2020) U.S. insulin prices 8 times higher than in other countries. (n.d.). Healthcare

Finance News. Retrieved April 13, 2021, from

Nair, R., & Kachan, P. (2017). Outcome tools for diabetes-specific quality of life. Canadian

Family Physician, 63(6), e310–e315. National Diabetes Statistics Report, 2020. (n.d.).

Nelson, K. M., Chapko, M. K., Reiber, G., & Boyko, E. J. (2005). The association between

health insurance coverage and diabetes care; data from the 2000 behavioral risk factor surveillance system. Health Services Research, 40(2), 361–372.

Pradhan, R. (n.d.). For insulin and other medications, rising costs aren’t slowing down.

Washington Post. Retrieved April 13, 2021, from

Rosenfeld, L. (2002). Insulin: Discovery and controversy. Clinical Chemistry, 48(12),


Polonsky, W. (2017) Understanding and assessing diabetes-specific quality of life. (n.d.).

Retrieved April 13, 2021, from,flexibility%2C%20and%20frequency%20of%20symptoms

Zhang, J. X., Huang, E. S., Drum, M. L., Kirchhoff, A. C., Schlichting, J. A., Schaefer, C. T.,

Heuer, L. J., & Chin, M. H. (2009). Insurance status and quality of diabetes care in community health centers. American Journal of Public Health, 99(4), 742–747.

Works Consulted

Cefalu, W. T., Dawes, D. E., Gavlak, G., Goldman, D., Herman, W. H., Nuys, K. V., Powers, A.

C., Taylor, S. I., & Yatvin, A. L. (2018). Insulin access and affordability working group: Conclusions and recommendations. Diabetes Care, 41(6), 1299–1311.

Hodgson, T. A., & Meiners, M. R. (1982). Cost-of-illness methodology: A guide to current

practices and procedures. The Milbank Memorial Fund Quarterly. Health and Society, 60(3), 429–462.

Holman, N., Knighton, P., Kar, P., O’Keefe, J., Curley, M., Weaver, A., Barron, E., Bakhai, C.,

Khunti, K., Wareham, N. J., Sattar, N., Young, B., & Valabhji, J. (2020). Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: A population-based cohort study. The Lancet Diabetes & Endocrinology, 8(10), 823–833.

Rajkumar, S. V. (2020). The high cost of insulin in the united states: An urgent call to action.

Mayo Clinic Proceedings, 95(1), 22–28.

Secrest, A. M., Costacou, T., Gutelius, B., Miller, R. G., Songer, T. J., & Orchard, T. J. (2011).

Association of socioeconomic status with mortality in type 1 diabetes: The pittsburgh epidemiology of diabetes complications (Edc) study. Annals of Epidemiology, 21(5), 367–373.

Sussman, M., Benner, J., Haller, M. J., Rewers, M., & Griffiths, R. (2020). Estimated lifetime

economic burden of type 1 diabetes. Diabetes Technology & Therapeutics, 22(2), 121–130.



How to Cite

Wang, A., & McGinn, L. (2022). The Association of Health Insurance and Quality of Life in Type One Diabetics. Journal of Student Research, 11(2).



AP Capstone™ Research